共 573 条
- [1] Abildgaard N(2003)Comparison of five biochemical markers of bone resorption in multiple myeloma: elevated pre-treatment levels of S-ICTP and U-Ntx are predictive for early progression of the bone disease during standard chemotherapy Br J Haematol 120 235-242
- [2] Brixen K(2000)Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patients Br J Haematol 109 24-29
- [3] Kristensen JE(2003)Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index Blood 102 1064-1069
- [4] Eriksen EF(1998)Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts Biochem Biophys Res Commun 242 703-709
- [5] Nielsen JL(1998)RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis Biochem Biophys Res Commun 253 395-400
- [6] Heickendorff L(1999)Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand Proc Natl Acad Sci USA 96 3540-3545
- [7] Fonseca R(2000)RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism Proc Natl Acad Sci USA 97 1566-1571
- [8] Trendle MC(2006)RANKL-RANK signaling in osteoclastogenesis and bone disease Trends Mol Med 12 17-25
- [9] Leong T(2001)Multiple myeloma disrupts the TRANCE/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression Proc Natl Acad Sci USA 98 11581-11586
- [10] Kyle RA(2006)Multiple myeloma bone disease: pathophysiology of osteoblast inhibition Blood 108 3992-3996